Atlas Trials

Study of Secutrelvir in Participants With COVID-19

Clinical trial NCT07746544 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07746544
Sponsor
Shionogi
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2026-07-20
Primary completion
2027-07-31
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.